Marietta Investment Partners’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,480	Closed	-$352K	–	169
2023 Q1	$352K	Sell	3,480 -100	-3%	-$10.1K	0.1%	136
2022 Q4	$428K	Buy	+3,580	New	+$428K	0.12%	127